403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Ogilvy Health Australia To Connect OTC Brands And Aussies With New Offering
(MENAFN- PRovoke)
SYDNEY - Ogilvy Health Australia is expanding its culture-focused capabilities, launching a new offering that brings non-prescription, over-the-counter (OTC) brands out of the lab, and into the zeitgeist.
Called OTC Influence, it provides a new, unique approach to marketing pharmacy brands that moves beyond the traditional emphasis on efficacy, ingredients and data, instead creating integrated campaigns that focus on key cultural insights.
By tapping into Ogilvy's health and influence expertise, OTC Influence will drive marketing programmes for OTC brands with a unique social-media-first approach that includes harnessing health influencers, impactful earned media and owned channel content. This will centre activity more on what a brand stands for, rather than just what it does.
Ultimately, OTC Influence will aim to“culturally connect OTC brands and products directly to trends, consumers insights and user attitudes,” explains Richard Brett, CEO Ogilvy Health ANZ.
“Bringing OTC brands into the heart of Australian culture is the critical next step for OTC marketing in Australia. This is where magic happens - at the intersection of brand attributes and cultural connection. It's about leveraging earned-first creativity and developing ideas so compelling, entertaining, or culturally relevant that people want to share them,” he said.
“The OTC Influence process starts with a deep dive into cultural insights, using data and listening tools to identify trends, phenomena, and consumer attitudes that create a new way to talk about health issues. This cultural hook then informs how the OTC brand provides commentary, a solution, or a new approach, moving it beyond its category and simple function and giving it a distinct point of view," added Rachel Stanton, Ogilvy Health's group managing director.
“By connecting the brands closely with culture, it will give OTC brands the opportunity to engage with consumers, pharmacists and retailers in their worlds, through their preferred channels in ways that resonate to get the brand both noticed and sold,” she said.
Ogilvy Health's Head of Consumer Health, Ben Hickey added:“Australia's OTC brands are some of the best known and trusted products in any sector. They are an integral part of our daily lives and deliver for people every day. But now the unconditional brand affinity we have with OTCs needs to be brought to life in new and culturally relevant ways.”
The launch of OTC Influence comes at a time of buoyancy for the sector; it has seen strong growth in Australia (3.26%) and the revenue generated in the OTC pharmaceuticals market is projected to reach A$6.75bn in 2026, it said in a statement. However, it is also highly competitive with more than 14,000 non-prescription products currently available to Australians.
The launch of OTC Influence also comes off the back of Ogilvy Health Australia's expanded consumer health offering which was unveiled last year following Hickey's hire.
“Even though the sector is growing, OTC brands themselves are under threat, having to work through an uncertain time with pressure from competitors, generics and cost-of-living pressures. OTC Influence can provide a clear path and strong engagement strategy for all OTC brands to help them successfully navigate these challenges,” Hickey said.
The launch of OTC Influence also builds on the Australian rollout last year of health Influence; a global capability, tailored locally, that provides pharmaceutical, healthcare and wellness brands access to the burgeoning influence economy.
Called OTC Influence, it provides a new, unique approach to marketing pharmacy brands that moves beyond the traditional emphasis on efficacy, ingredients and data, instead creating integrated campaigns that focus on key cultural insights.
By tapping into Ogilvy's health and influence expertise, OTC Influence will drive marketing programmes for OTC brands with a unique social-media-first approach that includes harnessing health influencers, impactful earned media and owned channel content. This will centre activity more on what a brand stands for, rather than just what it does.
Ultimately, OTC Influence will aim to“culturally connect OTC brands and products directly to trends, consumers insights and user attitudes,” explains Richard Brett, CEO Ogilvy Health ANZ.
“Bringing OTC brands into the heart of Australian culture is the critical next step for OTC marketing in Australia. This is where magic happens - at the intersection of brand attributes and cultural connection. It's about leveraging earned-first creativity and developing ideas so compelling, entertaining, or culturally relevant that people want to share them,” he said.
“The OTC Influence process starts with a deep dive into cultural insights, using data and listening tools to identify trends, phenomena, and consumer attitudes that create a new way to talk about health issues. This cultural hook then informs how the OTC brand provides commentary, a solution, or a new approach, moving it beyond its category and simple function and giving it a distinct point of view," added Rachel Stanton, Ogilvy Health's group managing director.
“By connecting the brands closely with culture, it will give OTC brands the opportunity to engage with consumers, pharmacists and retailers in their worlds, through their preferred channels in ways that resonate to get the brand both noticed and sold,” she said.
Ogilvy Health's Head of Consumer Health, Ben Hickey added:“Australia's OTC brands are some of the best known and trusted products in any sector. They are an integral part of our daily lives and deliver for people every day. But now the unconditional brand affinity we have with OTCs needs to be brought to life in new and culturally relevant ways.”
The launch of OTC Influence comes at a time of buoyancy for the sector; it has seen strong growth in Australia (3.26%) and the revenue generated in the OTC pharmaceuticals market is projected to reach A$6.75bn in 2026, it said in a statement. However, it is also highly competitive with more than 14,000 non-prescription products currently available to Australians.
The launch of OTC Influence also comes off the back of Ogilvy Health Australia's expanded consumer health offering which was unveiled last year following Hickey's hire.
“Even though the sector is growing, OTC brands themselves are under threat, having to work through an uncertain time with pressure from competitors, generics and cost-of-living pressures. OTC Influence can provide a clear path and strong engagement strategy for all OTC brands to help them successfully navigate these challenges,” Hickey said.
The launch of OTC Influence also builds on the Australian rollout last year of health Influence; a global capability, tailored locally, that provides pharmaceutical, healthcare and wellness brands access to the burgeoning influence economy.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment